Secukinumab for ankylosing spondylitis

Lancet. 2014 Mar 1;383(9919):780. doi: 10.1016/S0140-6736(14)60397-4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antirheumatic Agents / administration & dosage*
  • Female
  • Humans
  • Male
  • Spondylitis, Ankylosing / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents